Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada flag Canada · Delayed Price · Currency is CAD
9.65
+0.28 (2.99%)
Nov 3, 2026, 4:00 PM EST

Eupraxia Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6365231611477935
Market Cap Growth
57.12%225.34%9.66%85.89%125.87%-
Enterprise Value
4884411471275810
Last Close Price
9.6510.324.515.373.652.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.454.743.51124.328.081.83
P/TBV Ratio
4.407.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.0011.711.250.52
Net Debt / Equity Ratio
-1.02-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
2.322.101.230.320.531.12
Net Debt / FCF Ratio
3.452.761.100.430.631.31
Quick Ratio
15.7114.4410.741.016.0013.38
Current Ratio
16.0015.1211.101.026.0813.49
Return on Equity (ROE)
-66.70%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-43.66%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-43.50%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.68%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-8.54%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-47.80%-17.76%-40.52%-25.21%-55.45%-102.75%